1-Aminoindan | Human Plasma | 20 pg/mL | K2EDTA |
Abiraterone | Human Plasma | 0.2 ng/mL | K2EDTA |
Acalabrutinib/Metabolite M27 | Human Plasma | 1/1 ng/mL | K2EDTA |
Acetaminophen | Human Plasma | 75 ng/mL | K2EDTA |
Acetaminophen (with Tramadol) | Human Plasma | 75 ng/mL | K2EDTA |
Acetylsalicylic Acid | Human Plasma | 2.5 ng/mL | Sodium Fluoride/Potassium Oxalate |
Albendazole/Albendazole Sulfoxide (LR) | Human Plasma | 0.1/1 ng/mL | K2EDTA |
Ambrisentan | Human Plasma | 50 ng/mL | K2EDTA |
Amifampridine | Human Plasma | 150 pg/mL | K2EDTA |
Amlodipine | Human Plasma | 5 pg/mL | K2EDTA |
Amlodipine (with Lisinopril) | Human Plasma | 0.15 ng/mL | K2EDTA |
Amphetamine (D/L) Chiral | Human Plasma | 0.2/0.2 ng/mL | K2EDTA |
Amphetamine (D/L) Chiral | Human Plasma | 50 /50 pg/mL | K2EDTA |
Apalutamide | Human Plasma | 5 ng/mL | K2EDTA |
Apixaban | Human Plasma | 1 ng/mL | K2EDTA |
Apomorphine | Human Plasma | 50 pg/mL | K2EDTA |
Aprepitant | Human Plasma | 25 ng/mL | K2EDTA |
Aripiprazole | Human Plasma | 0.2 ng/mL | K2EDTA |
Atovaquone (with Proguanil) | Human Plasma | 25 ng/mL | K2EDTA |
Axitinib | Human Plasma | 0.5 ng/mL | K2EDTA |
Azithromycin | Human Plasma | 1 ng/mL | K2EDTA |
Bexarotene | Human Plasma | 1 ng/mL | K2EDTA |
Bisoprolol | Human Plasma | 0.2 ng/mL | K2EDTA |
Bromazepam | Hunam Plasma | 1 ng/mL | K2EDTA |
Budesonide | Human Plasma | 3 pg/mL | Sodium Fluoride/Potassium Oxalate |
Buprenorphine | Human Plasma | 1 pg/mL | K2EDTA |
Buprenorphine/Norbuprenorphine (with Naloxone) | Human Plasma | 25/20 pg/mL | K3EDTA |
Carglumic Acid (high range) | Human Plasma | 25 ng/mL | Sodium Heparin |
Carglumic Acid (low range) | Human Plasma | 10 ng/mL | Sodium Heparin |
CBD (with THC & 11-OH-THC) | Human Plasma | 50 pg/mL | K2EDTA |
Cefixime | Human Plasma | 50 ng/mL | K2EDTA |
Celecoxib | Dog Plasma | 1 ng/mL | K3EDTA |
Celecoxib | Dog Synovial Fluid | 1 ng/mL | K3EDTA |
Celecoxib | Rat Plasma | 1 ng/mL | K3EDTA |
Celecoxib | Human Plasma | 1 ng/mL | K2EDTA |
Chlorphenamine Maleate (Chiral) | Human Plasma | 50/50 pg/mL | K2EDTA |
Chlorzoxazone | Human Plasma | 0.1 µg/mL | K2EDTA |
Ciprofloxacin | Human Plasma | 10 ng/mL | K2EDTA |
Citalopram | Human Plasma | 0.5 ng/mL | K2EDTA |
Clindamycin | Human Plasma | 25 ng/mL | K2EDTA |
Clobazam/N-Desmethyclobazam | Human Plasma | 1/0.35 ng/mL | K2EDTA |
Clobazam/N-Desmethyclobazam | Human Plasma | 1/3 ng/mL | K2EDTA |
Clobetasol Propionate | Human Plasma | 40 pg/mL | K2EDTA |
Clonidine | Human Plasma | 10 pg/mL | K2EDTA |
Cysteamine | Human Plasma | 20 ng/mL | Sodium Heparin |
Dabigatran (free) | Human Plasma | 1 ng/mL | K2EDTA |
Dabigatran (total) | Human Plasma | 1 ng/mL | K2EDTA |
Dapsone | Human Plasma | 5 ng/mL | Sodium Fluoride/Potassium Oxalate |
Dasatinib | Human Plasma | 1 ng/mL | K2EDTA |
Deferasirox | Human Plasma | 40 ng/mL | K2EDTA |
Deferiprone | Human Serum | 50 ng/mL | N/A |
Desoximetasone | Human Plasma | 25 pg/mL | K2EDTA |
Dexlansoprazole | Human Plasma | 1 ng/mL | K2EDTA |
Dexmethylphenidate | Human Plasma | 100 pg/mL | Sodium Fluoride/Potassium Oxalate |
Diazepam | Human Plasma | 5 ng/mL | K2EDTA |
Dichlorphenamide | Human Plasma | 1 ng/mL | K2EDTA |
Dienogest | Human Plasma | 1 ng/mL | K2EDTA |
Dipyridamole | Human Plasma | 7 ng/mL | K2EDTA |
Dofetilide (with Mexiletine) | Human Plasma | 20 pg/mL/ 3 ng/mL | K2EDTA |
Dolutegravir (with Lamotrigine and Tenofovir) | Human Plasma | 20 ng/mL | K2EDTA |
Donepezil | Human Plasma | 100 pg/mL | K2EDTA |
Doxepine/Nordoxepin (High Range) | Human Plasma | 100/100 pg/mL | K2EDTA |
Doxepine/Nordoxepin (Low Range) | Human Plasma | 25/25 pg/mL | K2EDTA |
Doxycycline | Human Plasma | 20 ng/mL | K2EDTA |
Doxylamine (qualified method) | Human Plasma | 0.25 ng/mL | K2EDTA |
Droxidopa | Human Plasma | 10 ng/mL | K2EDTA |
Dutasteride | Human Plasma | 30 pg/mL | K2EDTA |
Edaravone (free) | Human Plasma | 2 ng/mL | K2EDTA |
Edaravone Sulfate/Edaravone Glucuronide | Human Plasma | 5/2 ng/mL | K2EDTA |
Efavirenz | Human Plasma | 10 ng/mL | K2EDTA |
Elagolix | Human Plasma | 5 ng/mL | K2EDTA |
Emtricitabine | Human Plasma | 10 ng/mL | K2EDTA |
Enzalutamide | Human Plasma | 510 ng/mL | K2EDTA |
Eplerenone (with Furosemide) | Human Plasma | 15 ng/mL | K2EDTA |
Erlotinib | Human Plasma | 5 ng/mL | K2EDTA |
Esomeprazole | Human Plasma | 1.5 ng/mL | K2EDTA |
Ethacrynic Acid | Human Plasma | 0.5 pg/mL | K2EDTA |
Ethinyl Estradiol (with Norethindrone) | Human Plasma | 1 pg/mL | K2EDTA |
Everolimus | Whole Blood | 0.2 ng/mL | K2EDTA |
Ezogabine | Human Plasma | 5 ng/mL | K2EDTA |
Felbamate | Dog Plasma | 200 ng/mL | K2EDTA |
Felbamate | Human Plasma | 200 ng/mL | K2EDTA |
Finasteride | Human Plasma | 0.5 pg/mL | K2EDTA |
Fingolimod | Whole Blood | 5 pg/mL | K2EDTA |
Fingolimod Phosphate | Whole Blood | 25 pg/mL | K2EDTA |
Flecainide | Human Plasma | 0.8 ng/mL | K2EDTA |
Fluconazole | Human Plasma | 50 ng/mL | K2EDTA |
Fluticasone Furoate | Human Plasma | 0.5 pg/mL | K3EDTA |
Fluticasone Propionate (with Salmeterol) | Human Plasma | 1 pg/mL | K2EDTA |
Formoterol | Human Plasma | 0.3 pg/mL | Sodium Fluoride/Potassium Oxalate |
Furosemide (with Eplerenone) | Human Plasma | 15 ng/mL | K2EDTA |
Gabapentin | Human Plasma | 10 ng/mL | K2EDTA |
Gamma Hydroxybutyrate (GHB) | Human Plasma | 0.5 µg/mL | K2EDTA |
Gefitinib | Human Plasma | 1 ng/mL | K2EDTA |
Gepirone | Human Plasma | 20/20/20 pg/mL | K2EDTA |
Gliclazide | Human Plasma | 5 ng/mL | K2EDTA |
Hydrocodone | Human Plasma | 0.1 ng/mL | K2EDTA |
Hydroxymethyl Tolterodine (5HMT) | Human Plasma | 20 pg/mL | K2EDTA |
Ibrutinib (High Range) | Human Plasma | 1.50 ng/mL | K2EDTA |
Ibrutinib (Low Range) | Human Plasma | 0.5 ng/mL | K2EDTA |
Ibuprofen | Human Plasma | 100 ng/mL | K2EDTA |
Idelalisib | Human Plasma | 10 ng/mL | K2EDTA |
Imatinib/N-Desmethyl Imatinib | Human Plasma | 10/2 ng/mL | K2EDTA |
Indapamide | Human Whole Blood | 0.25 ng/mL | K2EDTA |
Ketamine/Norketamine | Human Plasma | 0.4/4 ng/mL | K2EDTA |
Lacosamide | Human Plasma | 100 ng/mL | K2EDTA |
Lamivudine (with Dolutegravir & Tenofovir) | Human Plasma | 50 ng/mL | K2EDTA |
Lamotrigine | Human Plasma | 10 ng/mL | K2EDTA |
Lansoprazole | Human Plasma | 1 ng/mL | K2EDTA |
Lenalidomide | Human Plasma | 1 ng/mL | K2EDTA |
Lenvatinib | Human Plasma | 0.5 ng/mL | K2EDTA |
Leuprolide | Human Plasma | 50 pg/mL | K2EDTA |
Levetiracetam | Human Plasma | 0.2 µg/mL | K2EDTA |
Levetiracetam | Human Plasma | 50 ng/mL | K2EDTA |
Levomilnacipran | Human Plasma | 1 ng/mL | K2EDTA |
Levothyroxine | Human Serum | 10 ng/mL | N/A |
Lidocaine (with Prilocaine) | Human Plasma | 100 pg/mL | K2EDTA |
Lisdexamfetamine/D-Amphetamine | Human Plasma | 0.4/0.8 ng/mL | K2EDTA |
Lisinopril (with Amlodipine) | Human Plasma | 1.5 ng/mL | K2EDTA |
Loxapine/7 and 8-Hydroxy Loxapine | Human Plasma | 10/10/10 pg/mL | K2EDTA |
Macitentan | Human Plasma | 1 ng/mL | K2EDTA |
Mesalamine | Human Plasma | 2 ng/mL | K2EDTA |
Metformin | Human Plasma | 6 ng/mL | K2EDTA |
Methylnaltrexone | Human Plasma | 0.1 ng/mL | K2EDTA |
Methylphenidate | Human Plasma | 20 pg/mL | Sodium Fluoride/Potassium Oxalate |
Methylphenidate | Human Plasma | 100 pg/mL | Sodium Fluoride/Potassium Oxalate |
Metolazone | Human Plasma | 0.5 ng/mL | K2EDTA |
Metoprolol | Human Plasma | 0.6 ng/mL | K2EDTA |
Mexiletine (with Dofetilide) | Human Plasma | 3 ng/mL | K2EDTA |
Midostaurin/CGP62221/CGP52421 | Human Plasma | 7.5/5/5 ng/mL | K2EDTA |
Mirtazapine | Human Plasma | 0.25 ng/mL | K2EDTA |
Mometasone Furorate | Human Plasma | 0.5 pg/mL | K3EDTA |
Monomethyl Fumarate | Human Plasma | 25 ng/mL | Sodium Fluoride/Potassium Oxalate |
Morphine/Morphine 6-Glucuronide | Human Plasma | 0.2/0.4 ng/mL | K2EDTA |
Naloxone (Free) | Human Urine | 0.4 ng/mL | N/A |
Naloxone (Free) (with Buprenorphine and Norbuprenorphine) | Human Plasma | 3 pg/mL | K2EDTA |
Naloxone (with Oxycodone) | Human Plasma | 1 pg/mL | K2EDTA |
Naloxone-3 β D glucoronide | Human Plasma | 50 pg/mL | K3EDTA |
Naltrexone/6β-Naltrexol (High Range) | Human Plasma | 20/20 pg/mL | K2EDTA |
Naltrexone/6β-Naltrexol (Low Range) | Human Plasma | 0.5/0.5 pg/mL | K2EDTA |
Nebivolol | Human Plasma | 100 pg/mL | K2EDTA |
Neratinib | Human Plasma | 50 pg/mL | K2EDTA |
Nicotine/Cotinine | Human Plasma | 0.2/2 ng/mL | K2EDTA |
Nifedipine | Human Plasma | 0.1 ng/mL | K2EDTA |
Nitrofurantoin | Human Plasma | 0.2 ng/mL | K2EDTA |
Nitroglycerin (NTG), 1,2-DNG/1,3-DNG | Human Plasma | 20/20/20 pg/mL | K2EDTA |
Norethindrone (with ethinyl estradiol) | Human Plasma | 25 pg/mL | K2EDTA |
Nortriptyline | Human Plasma | 0.2 ng/mL | K2EDTA |
Obeticholic Acid | Human Plasma | 500/500/100 pg/mL | K2EDTA |
Octreotide | Rabbit Plasma | 0.25 ng/mL | K2EDTA |
Omeprazole | Human Plasma | 1 ng/mL | K2EDTA |
Oxycodone | Human Plasma | 0.25 ng/mL | K2EDTA |
Oxycodone (with naloxone) | Human Plasma | 50 pg/mL | K2EDTA |
Oxymorphone/6-Hydroxyoxymorphone | Human Plasma | 5/10/100 pg/mL | K2EDTA |
Oxymorphone/Naloxone/Oxycodone | Human Plasma | 50/25 pg/mL | K2EDTA |
Palbociclib | Human Plasma | 0.5 ng/mL | K2EDTA |
Paliperidone | Human Plasma | 100 pg/mL | K2EDTA |
Pazopanib | Human Plasma | 100 ng/mL | K2EDTA |
Perindopril/ Perindoprilat/Indapamide | Human Plasma | 500/250/100 pg/mL | K2EDTA |
Pirfenidone | Human Plasma | 100 ng/mL | K2EDTA |
Pramipexole (with Rasagaline) | Human Plasma | 20 pg/mL | K2EDTA |
Pramipexole (with Rasagaline) | Human Plasma | 10 pg/mL | K2EDTA |
Pregabalin | Human Plasma | 25 ng/mL | K2EDTA |
Prilocaine (with Lidocaine) | Human Plasma | 25 pg/mL | K2EDTA |
Primidone | Human Plasma | 20 ng/mL | K2EDTA |
Progesterone | Human Plasma | 50 pg/mL | K2EDTA |
Progesterone | Human Plasma | 0.2 ng/mL | K2EDTA |
Proguanil (with Atovaquone) | Human Plasma | 1 ng/mL | K2EDTA |
Psilocybin/Psilocin | Human Plasma | 500/100 pg/mL | K2EDTA |
Pyridoxine (qualified method) | Human Plasma | 50 pg/mL | K2EDTA |
Rasagline (with Pramipexole) | Human Plasma | 20 pg/mL | K2EDTA |
Rasagline (with Pramipexole) | Human Plasma | 10 pg/mL | K2EDTA |
Regorafenib/Regorafenib-N-Oxide (M2) | Human Plasma | 10/4 ng/mL | K3EDTA |
Ribociclib | Human Plasma | 2 ng/mL | K2EDTA |
Risperidone | Human Plasma | 0.1 ng/mL | K2EDTA |
Rivaroxaban | Dog Plasma | 0.5 ng/mL | K2EDTA |
Rivaroxaban | Human Plasma | 0.5 ng/mL | K2EDTA |
Rizatriptan | Human Plasma | 0.15 ng/mL | K2EDTA |
Roflumilast | Human Plasma | 20 pg/mL | K2EDTA |
Rosuvastatin | Human Plasma | 100 pg/mL | K2EDTA |
Sacubitril (High Range) (with Valsartan) | Human Plasma | 5 ng/mL | K2EDTA |
Sacubitril (Low Range) (with Valsartan) | Human Plasma | 1 ng/mL | K2EDTA |
Sacubitril (Mid Range) (with Valsartan) | Human Plasma | 1 ng/mL | K2EDTA |
Salicyclic Acid | Human Plasma | 25 ng/mL | Sodium Fluoride/Potassium Oxalate |
Salmeterol (with Fluticasone propionate) | Human Plasma | 1 pg/mL | K2EDTA |
Sildenafil | Human Plasma | 0.75 ng/mL | K2EDTA |
Silodosin/Silodosin-β-D-Glucuronide | Human Plasma | 0.5/0.5 ng/mL | K2EDTA |
Sitagliptin | Human Plasma | 10 ng/mL | K2EDTA |
Sitagliptin | Human Plasma | 1 ng/mL | K2EDTA |
Sofosbuvir | Human Plasma | 5 ng/mL | K2EDTA |
Solifenacin (with Tamsulosin) | Human Plasma | 100 pg/mL | K2EDTA |
Sulfamethoxazole (with Trimethoprim) | Human Plasma | 250/10 ng/mL | K2EDTA |
Tacrolimus | Whole Blood | 100 pg/mL | K2EDTA |
Tacrolimus (LR) | Whole Blood | 50 pg/mL | K2EDTA |
Tadalafil | Human Plasma | 3 ng/mL | K2EDTA |
Tamsulosin (with Solifenacin) | Human Plasma | 100 pg/mL | K2EDTA |
Tapentadol | Human Plasma | 0.5 ng/mL | K2EDTA |
Telmisartan | Human Plasma | 2 ng/mL | K3EDTA |
Tenofovir (with Dolutegravir and Lamivudine) | Human Plasma | 5 ng/mL | K2EDTA |
Tenofovir Alafenamide | Human Plasma | 1 ng/mL | K2EDTA |
Tetrabenazine/α-and β-hydroxy Tetrabenazine | Human Plasma | 20 pg/mL/0.25/0.25 ng/mL | K2EDTA |
Thalidomide | Human Plasma | 10 ng/mL | K2EDTA |
THC/11-OH THC (with CBD) | Human Plasma | 100/100/100 pg/mL | K2EDTA |
Theophylline | Human Plasma | 50 ng/mL | K2EDTA |
Thiorphan | Human Plasma | 2 ng/mL | K2EDTA |
Ticagrelor/Deshydroxyethoxy Ticagrelor | Human Plasma | 5/2.5 ng/mL | K2EDTA |
Tiotropium | Human Plasma | 0.5 pg/mL | K2EDTA |
Triamcinolone Acetonide | Human Plasma | 10 pg/mL | K2EDTA |
Trientine/N1-Acetyitriethyienetetramine | Human Plasma | 10 ng/mL | K2EDTA |
Trimethoprim (with sulfamethoxazole) | Human Plasma | 10 ng/mL | K2EDTA |
Ulipristal Acetate | Human Plasma | 0.25 ng/mL | K2EDTA |
Ulipristal Acetate/N-Desmethyl Ulipristal Acetate | Human Plasma | 1/0.5 ng/mL | K2EDTA |
Valsartan (with hydrochlorothiazide) | Human Plasma | 20 ng/mL | K2EDTA |
Valsartan (with Sacubitril) High Range | Human Plasma | 10 ng/mL | K2EDTA |
Valsartan (with Sacubitril) Low Range | Human Plasma | 1 ng/mL | K2EDTA |
Valsartan (with Sacubitril) Med Range | Human Plasma | 2.5 ng/mL | K2EDTA |
Varenicline | Human Plasma | 100 pg/mL | K2EDTA |
Vigabatrin | Human Plasma | 0.25 µg/mL | K2EDTA |
Vildagliptin | Human Plasma | 2 ng/mL | K2EDTA |
Voriconazole | Human Plasma | 10 ng/mL | K2EDTA |